Impact of disease and patient specific factors on the efficacy and safety of advanced therapies in moderate-to-severe Ulcerative colitis: An individual patient data meta-analysis of multiple clinical trials

Ulcerative Colitis (UC) is a long-term condition that causes inflammation in the large intestine, leading to symptoms such as abdominal pain and bloody stools. If not properly managed, it can significantly impact a person’s quality of life. In recent years, the number of people diagnosed with UC has been increasing. Early and effective disease control is crucial to prevent complications.

One challenge in managing UC is that symptoms alone may not always reflect the true state of the disease. Even when symptoms improve, inflammation can persist at a microscopic level, which may lead to worsening disease over time. Currently, a medical procedure called endoscopy is used to assess the health of the intestine. This involves inserting a small camera into the intestine to check for inflammation. While endoscopy provides a reliable assessment of disease activity, it is expensive, requires sedation, and must be repeated at regular intervals.

This study aims to identify factors that influence the healing of the intestine in UC patients. Some of these factors can be modified, meaning they can be controlled through medical treatment or lifestyle changes. Others cannot be changed but can still help guide treatment decisions. Understanding these factors will help predict long-term disease control and improve personalized treatment strategies.

In addition, our research explores the use of advanced therapies for patients with severe UC. While these treatments can be highly effective, they also carry risks of serious side effects, some of which may be life-threatening. Because of this, a one-size-fits-all approach to treatment may not be suitable.

Currently, it is unclear whether the side effects seen in patients using advanced therapies are caused by the medications themselves or by other factors, such as the severity of the disease or pre-existing health conditions. To better understand this, our study will compare the effects of advanced therapy to a placebo (a treatment with no active drug) in patients with similar disease severity. This will help determine whether the side effects are truly medication-related or part of the disease’s natural course.

By improving our understanding of UC treatment and the factors affecting intestinal healing, this research will contribute to more effective and safer treatment strategies for patients.